These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23722320)

  • 1. Plasma levels of phospholipase A2-IIA in patients with different types of malignancies: prognosis and association with inflammatory and coagulation biomarkers.
    Menschikowski M; Hagelgans A; Schuler U; Froeschke S; Rosner A; Siegert G
    Pathol Oncol Res; 2013 Oct; 19(4):839-46. PubMed ID: 23722320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.
    Kupert E; Anderson M; Liu Y; Succop P; Levin L; Wang J; Wikenheiser-brokamp K; Chen P; Pinney SM; Macdonald T; Dong Z; Starnes S; Lu S
    BMC Cancer; 2011 Dec; 11():513. PubMed ID: 22151235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
    Oleksowicz L; Liu Y; Bracken RB; Gaitonde K; Burke B; Succop P; Levin L; Dong Z; Lu S
    Prostate; 2012 Jul; 72(10):1140-9. PubMed ID: 22127954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum secretory phospholipase A2-IIa (sPLA2-IIA) levels in patients surviving acute myocardial infarction.
    Xin H; Chen ZY; Lv XB; Liu S; Lian ZX; Cai SL
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):999-1004. PubMed ID: 23661511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group IIA Secretory Phospholipase A
    Akinkuolie AO; Lawler PR; Chu AY; Caulfield M; Mu J; Ding B; Nyberg F; Glynn RJ; Ridker PM; Hurt-Camejo E; Chasman DI; Mora S
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1182-1190. PubMed ID: 31070471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality.
    Snider JM; You JK; Wang X; Snider AJ; Hallmark B; Zec MM; Seeds MC; Sergeant S; Johnstone L; Wang Q; Sprissler R; Carr TF; Lutrick K; Parthasarathy S; Bime C; Zhang HH; Luberto C; Kew RR; Hannun YA; Guerra S; McCall CE; Yao G; Del Poeta M; Chilton FH
    J Clin Invest; 2021 Oct; 131(19):. PubMed ID: 34428181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A, phospholipase A₂-IIA and C-reactive protein as inflammatory biomarkers for prostate diseases.
    Menschikowski M; Hagelgans A; Fuessel S; Mareninova OA; Asatryan L; Wirth MP; Siegert G
    Inflamm Res; 2013 Dec; 62(12):1063-72. PubMed ID: 24061501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells.
    Dong Z; Meller J; Succop P; Wang J; Wikenheiser-Brokamp K; Starnes S; Lu S
    Int J Oncol; 2014 Sep; 45(3):978-84. PubMed ID: 24913497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer.
    Dong Z; Liu Y; Scott KF; Levin L; Gaitonde K; Bracken RB; Burke B; Zhai QJ; Wang J; Oleksowicz L; Lu S
    Carcinogenesis; 2010 Nov; 31(11):1948-55. PubMed ID: 20837598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD64 and Group II Secretory Phospholipase A2 (sPLA2-IIA) as Biomarkers for Distinguishing Adult Sepsis and Bacterial Infections in the Emergency Department.
    Tan TL; Ahmad NS; Nasuruddin DN; Ithnin A; Tajul Arifin K; Zaini IZ; Wan Ngah WZ
    PLoS One; 2016; 11(3):e0152065. PubMed ID: 27003588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Type II Secretory Phospholipase A2 Increases the Risk of Early Atherosclerosis in Patients with Newly Diagnosed Metabolic Syndrome.
    Sun CQ; Zhong CY; Sun WW; Xiao H; Zhu P; Lin YZ; Zhang CL; Gao H; Song ZY
    Sci Rep; 2016 Dec; 6():34929. PubMed ID: 27941821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Secretory Phospholipase A2 Group IIa in Breast Cancer and Correlation to Prognosis in a Cohort of Advanced Breast Cancer Patients.
    Jespersen SS; Stovgaard ES; Nielsen D; Christensen TD; Buhl ASK; Christensen IJ; Balslev E
    Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):e5-e9. PubMed ID: 32217848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue.
    Tribler L; Jensen LT; Jørgensen K; Brünner N; Gelb MH; Nielsen HJ; Jensen SS
    Anticancer Res; 2007; 27(5A):3179-85. PubMed ID: 17970059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study.
    Mallat Z; Benessiano J; Simon T; Ederhy S; Sebella-Arguelles C; Cohen A; Huart V; Wareham NJ; Luben R; Khaw KT; Tedgui A; Boekholdt SM
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1177-83. PubMed ID: 17303774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris.
    Kugiyama K; Ota Y; Sugiyama S; Kawano H; Doi H; Soejima H; Miyamoto S; Ogawa H; Takazoe K; Yasue H
    Am J Cardiol; 2000 Oct; 86(7):718-22. PubMed ID: 11018189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer.
    Wang M; Hao FY; Wang JG; Xiao W
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2648-54. PubMed ID: 25317799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point of care testing of phospholipase A2 group IIA for serological diagnosis of rheumatoid arthritis.
    Liu NJ; Chapman R; Lin Y; Mmesi J; Bentham A; Tyreman M; Abraham S; Stevens MM
    Nanoscale; 2016 Feb; 8(8):4482-5. PubMed ID: 26854217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
    Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B
    Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halogenated phospholipids regulate secretory phospholipase A2 group IIA activity.
    Korotaeva A; Samoilova E; Pavlunina T; Panasenko OM
    Chem Phys Lipids; 2013; 167-168():51-6. PubMed ID: 23438648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of PLA2G2A single nucleotide polymorphisms with type IIa secretory phospholipase A2 level but not its activity in patients with stable coronary heart disease.
    Shuvalova YA; Khasanova ZB; Kaminnaya VI; Samoilova EV; Korotaeva AA; Rubanovich AV; Kaminnyi AI
    Gene; 2015 Jun; 564(1):29-34. PubMed ID: 25794429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.